Search Result "PPARαactivator."
Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 1 Year: 2013 Page: 70-77
Author(s): Miriam Melis, Gianfranca Carta, Marco Pistis, Sebastiano Banni
PPARα/HNF4α Interplay on Diversified Responsive Elements. Relevance in the Regulation of Liver Peroxisomal Fatty Acid Catabolism
Journal: Current Drug Metabolism
Volume: 13 Issue: 10 Year: 2012 Page: 1436-1453
Author(s): Julie Chamouton,Norbert Latruffe
Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 24 Year: 2014 Page: 2803-2821
Author(s): Marco Fidaleo,Francesca Fanelli,Maria Paola Ceru,Sandra Moreno
Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 7 Year: 2011 Page: 775-786
Author(s): R. E. Nunez-Anita, M. Cajero-Juarez, C. Aceves
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 3 Year: 2003 Page: 239-251
Author(s): S. Theocharis, A. Margeli, G. Kouraklis
From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2 Issue: 1 Year: 2008 Page: 24-28
Author(s): Selcuk Dagdelen
Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 1 Year: 2021 Page: 3193-3215
Author(s): Suvadeep Mal,Ashish Ranjan Dwivedi,Vijay Kumar,Naveen Kumar,Bhupinder Kumar,Vinod Kumar
Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 219-236
Author(s): M. I. Panadero, M. C. Gonzalez, E. Herrera, C. Bocos
Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Journal: Current Molecular Pharmacology
Volume: 5 Issue: 2 Year: 2012 Page: 255-263
Author(s): Satyam Sarma
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 25 Year: 2017 Page: 3677-3688
Author(s): Qingqing Wang,Mustapha Umar Imam,Zhang Yida,Fudi Wang